|Selected news articles which highlight important policy issues.||
News: Weekly Archives
News for the week of 09-23-2006
Target Offers Cheap Drugs Too
Following Wal-Mart's lead, Target has announced that it will offer hundreds of generic prescription drugs at $4 for a thirty–day supply. These announcements, by two of America’s leading retailers, underscore the reality that the U.S. has the most robust price competition in the world between branded and generic drugs—a competition that, by all measures is set to intensify in the next several years some of the industry's leading blockbuster drugs go off–patent.
On Thursday, Wal–Mart shocked the retail industry by saying it would offer 30–day supplies of 291 generic drugs for $4 in Tampa immediately, expand to the rest of Florida on Jan. 1 and then roll it out to the rest of the nation.
FDA Told U.S Drug System Is Broken
The Institute of Medicine released the results of a two year study into of FDA's drug safety programs—and the findings have been interpreted as a scathing indictment of the agency.
The federal system for approving and regulating drugs is in serious disrepair, and a host of dramatic changes are needed to fix the problem, a blue–ribbon panel of government advisers concluded yesterday in a long–awaited report.
We'll write more on this later, since it is a very complex issue—but on first glance, some of its recommendations are bound to be very controversial. For instance, one recommendation, that direct to consumer advertising be prohibited during a new drug's first few years on the market, raises substantial 1st Amendment issues.
|home spotlight commentary research events news about contact links archives|